Knockouts of some “cancer drivers” of DLBCL, including BCL2, BCL6, NFKBIA and CD70, showed only modest promotional effects on cell proliferation (Supplementary Table S1). Here, BCL2 is linked to diffuse large B-cell lymphoma.